ASML HOLDING 1 676.000 € (+1,18 %) 
BASTIDE LE CONFORT 23.500 € (-0,21 %) DERICHEBOURG 9.955 € (-1,73 %) SOITEC 116.500 € (-6,58 %) SANOFI 73.340 € (-2,06 %) LUMIBIRD 24.650 € (+0,20 %) SCHNEIDER ELECTRIC 291.000 € (+2,92 %) HAFFNER ENERGY 0.253 € (-6,99 %) SAFRAN 333.500 € (+2,93 %) THALES 232.600 € (+0,69 %) LVMH 505.100 € (-1,15 %) 
MAROC TELECOM 9.100 € (+0,44 %) 
ARCELORMITTAL SA 55.860 € (-3,39 %) EUTELSAT COMMUNIC. 2.375 € (-7,01 %) CIECHARGEURSINVEST 8.260 € (-1,78 %) CARREFOUR 15.425 € (-6,17 %) BNP PARIBAS ACT.A 101.100 € (-0,10 %) VINCI 130.650 € (+0,27 %) AHOLD DEL 34.520 € (-2,46 %) AXA 42.400 € (-0,31 %) ADYEN 903.800 € (+1,74 %) PROSUS 39.090 € (-0,31 %) SAINT GOBAIN 79.760 € (+1,12 %) AIR LIQUIDE 167.120 € (+0,13 %) LAKEFRONT BIOTHER. 24.580 € (-0,73 %) EURONEXT 146.300 € (-1,48 %) EDENRED 24.230 € (+17,17 %) SPIE 50.450 € (+0,30 %) WOLTERS KLUWER 58.200 € (-2,68 %) ONE EXPERIENCE 0.362 € (-15,54 %) NANOBIOTIX 30.400 € (-0,91 %) 
MOTA ENGIL 4.598 € (-2,38 %) SAFE 0.570 € (+1,79 %) STELLANTIS NV 5.570 € (-3,65 %) REMY COINTREAU 45.420 € (+2,76 %) SCOR SE 31.140 € (-0,70 %) WINAMP GROUP 0.386 € (-1,28 %) 
LLAMA GROUP 0.386 € (-1,28 %) VALEO 13.410 € (-5,06 %) EXAIL TECHNOLOGIES 106.400 € (+0,66 %) RAMSAY GEN SANTE 11.000 € (-1,35 %) AIRBUS 191.940 € (+2,63 %) JCDECAUX 19.380 € (-1,42 %) INNATE PHARMA 1.598 € (+1,14 %) BE SEMICONDUCTOR 317.800 € (+2,48 %) VERALLIA 19.480 € (-2,01 %) PLANISWARE 18.000 € (-3,23 %) AKZO NOBEL 59.620 € (+1,05 %) 
SHELL PLC 34.210 € (-2,56 %) RELX 27.220 € (-4,02 %) VOPAK 45.100 € (-0,88 %) ASM INTERNATIONAL 1 070.500 € (+2,34 %) THERMADOR GROUPE 69.300 € (-0,72 %) OSE IMMUNO 3.584 € (-4,32 %) BOLLORE 5.400 € (-0,74 %) LECTRA 16.660 € (+0,73 %) KERING 276.550 € (+4,40 %) BUREAU VERITAS 26.210 € (+0,54 %) ALTAREA 96.300 € (-0,52 %) IMERYS 22.520 € (-0,09 %) |
14/02/2023 10:05
EQS-Adhoc: Elanix Biotechnologies AG: RESIGNATION AND NOMINATION IN THE SUPERVISORY BOARDEQS-Ad-hoc: Elanix Biotechnologies AG / Key word(s): Personnel/Personnel ELANIX BIOTECHNOLOGIES AG: RESIGNATION AND NOMINATION IN THE SUPERVISORY BOARD
Frankfurt, Feb 10, 2023 – The Chairman of the Supervisory Board of Elanix Biotechnologies AG (“Company”, “Elanix”) Marco Christen notified the CEO that Yves Bonnard resigned from the Supervisory Board due to work commitments. The Management Board would like to thank Yves Bonnard for his engagement for the Supervisory Board.
The District Court in Berlin has appointed successors, following the Board’s proposal of one suitable candidate.
The Supervisory Board of Elanix Biotechnologies AG (“Company”, “Elanix”) has nominated by juridical order Jean-Frederic Berthoud to become member of the Supervisory Board with immediate effect.
Today, the Elanix Supervisory Board Marco Christen as Chairman of the Board and Murielle Michetti as Vice Chairman appointed and welcomed Jean-Frédéric Berthoud as a new member of the Supervisory Board. Mr. Berthoud, as a retired director of the Department of Economy of the Canton of Vaud, will be a valuable asset for the strategic development of Elanix.
Lee-Ann Laurent-Applegate Interim CEO
14-Feb-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
1558785 14-Feb-2023 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||||||||||
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière